Novartis businesses and research teams have a worldwide presence.
Transforming the way we treat eye diseases and conditions.
Discovering new drugs to change the practice of medicine.
The Innovative Medicines Division has two business units:
Novartis Pharmaceuticals commercializes innovative, patented primary care and specialty medicines to enhance health outcomes for patients and health-care providers.
Novartis Oncology commercializes a portfolio of patented oncology, hematology and rare disease medicines to address the medical needs of people with cancer and related diseases.
Offering patients affordable, high-quality medicines.
This site is intended for a global audience.